Real-World Evidence: Why Are We Still Waiting?

Temporomandibular disorders have a significant impact on patients. Accelerated pathways for medical products have sped access to new medical products but have not come with better post market data as was promised by law and policy. Real-world evidence is still not available to evaluate medical products to treat patients with temporormandibular disorders. The coordinated registry networks offer a strong base for producing useful evidence but require more investment.